As shown in Figure 3, in participants without known HF, those with a cancer diagnosis exhibited significantly higher (p < 0.01) average levels of NT-proBNP (316.33 pg/mL) than those without cancer (151.90 pg/mL). Here, NPPB is linked to cancer.